Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers. | Front Immunol | 2021 | 34557180 | PubTator, text mining | PubMed |
| Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP. | Neurotherapeutics | 2021 | 34549385 | PubTator, text mining | PubMed |
| Identification of candidate regulators of mandibular bone loss in FcγRIIB-/- Mice. | Sci Rep | 2021 | 34548536 | PubTator, text mining | PubMed |
| Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy. | Nature | 2021 | 34547765 | PubTator, text mining | PubMed |
| A new approach to produce IgG4-like bispecific antibodies. | Sci Rep | 2021 | 34545109 | PubTator, text mining | PubMed |
| PhenClust, a standalone tool for identifying trends within sets of biological phenotypes using semantic similarity and the Unified Medical Language System metathesaurus. | JAMIA Open | 2021 | 34541463 | PubTator, text mining | PubMed |
| Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma. | Front Oncol | 2021 | 34540695 | PubTator, text mining | PubMed |
| All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. | EPMA J | 2021 | 34539937 | PubTator, text mining | PubMed |
| Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia. | Oncol Lett | 2021 | 34539852 | PubTator, text mining | PubMed |
| Immune Dysregulation in IgG4-Related Disease. | Front Immunol | 2021 | 34539675 | PubTator, text mining | PubMed |
| Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma. | J Gastrointest Oncol | 2021 | 34532139 | PubTator, text mining | PubMed |
| Application of Genetic Studies to Flow Cytometry Data and Its Impact on Therapeutic Intervention for Autoimmune Disease. | Front Immunol | 2021 | 34531863 | PubTator, text mining | PubMed |
| Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia. | J Hematol Oncol | 2021 | 34530888 | PubTator, text mining | PubMed |
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. | J Thorac Dis | 2021 | 34527339 | PubTator, text mining | PubMed |
| Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment. | Mol Neurodegener | 2021 | 34526055 | PubTator, text mining | PubMed |
| Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. | Nat Med | 2021 | 34522051 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. | Nat Commun | 2021 | 34521850 | PubTator, text mining | PubMed |
| Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. | Mol Ther Oncolytics | 2021 | 34514097 | PubTator, text mining | PubMed |
| The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies. | Front Immunol | 2021 | 34512662 | PubTator, text mining | PubMed |
| Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments. | Cancers (Basel) | 2021 | 34503270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=61